Brugia Malayi - Clark Science Center - Smith College
Brugia Malayi - Clark Science Center - Smith College
Brugia Malayi - Clark Science Center - Smith College
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Development of a Tandem Diels-Alder/Pauson-Khand Reaction for the<br />
Synthesis of Tetracycles Mediated by a Cobalt-Complexed Alkyne<br />
Elsa Hinds and Zulema Peralta<br />
The ultimate goal of this project is to cobalt-complex tetraenyne, 12, which will promote a tandem Diels-Alder/Pauson-Khand<br />
reaction to form tetracycle 14. Previous work on this project developed the current synthetic scheme and the plan for this<br />
summer was to continue the scheme in hope of synthesizing acyclic precursor 12. Previous work had successfully synthesized<br />
1-7. Summer work focused on optimizing the Sonogashira reaction (6-7) and Suzuki coupling forming 8. Once 8 was formed, the<br />
synthesis would continue with steps previously completed on a similar acyclic precursor.<br />
Optimization of the Sonogashira reaction on 6 was imperative because previously the largest yield was 50%, which in a 10-<br />
step synthesis is not optimal. To accomplish this, different purification conditions were employed via column chromatography<br />
as well as changing the palladium catalyst from Pd(PPh 3<br />
) 4<br />
to bench-stable Pd(PPh 3<br />
) 2<br />
Cl 2<br />
. Toward the end of the summer the Ph<br />
substrate was changed to a TMS group, and the purification was simple. While the Sonogashira conditions were being optimized,<br />
Suzuki reactions were being performed on pure 7, and the Ph Sonogashira product yielded pure 8 after optimization with base<br />
conditions. Once the pure TMS 7 was available, Suzuki reactions were attempted to no avail. This was likely due to the fact<br />
that TMS alkynes are frequently deprotected in base conditions so a third, alkyl substrate has been tested with success in the<br />
Sonogashira. Once the Sonogashira is optimized, steps toward 12 will continue in the fall. (Supported by the Howard Hughes<br />
Medical Institute and American Chemical Society Fellowship)<br />
Adviser: Kevin Shea<br />
2012<br />
72